By Business/Source
Currency:USD
2023/FY
Stock NameRevenueRatio
Developing novel small molecule therapeutics to treat unmet medical needs in immune-mediated disease7M100.00%
By Country/Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States7M100.00%